Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Hepion Pharmaceuticals, Inc. (HEPA) had Debt to Equity Ratio of -1.56 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-13.19M |
|
-- |
|
-- |
|
$19.35M |
|
$-19.35M |
|
$3.18M |
|
$-16.16M |
|
$-16.16M |
|
$-13.19M |
|
$-13.19M |
|
$-13.19M |
|
$-13.19M |
|
$-19.35M |
|
$-18.05M |
|
0.12M |
|
0.12M |
|
$-107.35 |
|
$-107.35 |
|
| Balance Sheet Financials | |
$1.61M |
|
-- |
|
$0.00M |
|
$1.61M |
|
$3.14M |
|
-- |
|
$0.33M |
|
$3.48M |
|
$-3.56M |
|
$-1.86M |
|
$-1.86M |
|
0.14M |
|
| Cash Flow Statement Financials | |
$-18.22M |
|
$-0.60M |
|
$4.35M |
|
$14.79M |
|
$0.41M |
|
$-14.38M |
|
$0.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.51 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-1.56 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
370.73% |
|
708.00% |
|
-817.51% |
|
708.00% |
|
$-13.41 |
|
$-148.10 |
|
$-148.10 |
|